OMEROS CORP Gain (Loss) on Termination of Lease
OMEROS CORP (OMER) reported Gain (Loss) on Termination of Lease of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2023-11-09
- OMEROS CORP gain (loss) on termination of lease for the quarter ending 2022-03-31 was $454.00K.
- OMEROS CORP gain (loss) on termination of lease for fiscal 2022 was $454.00K.
| Period end | Gain (Loss) on Termination of Lease | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | ||||
| 2022-12-31 | $454.00K 10-K · filed 2023-03-13 | ||||
| 2022-09-30 | $454.00K 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | $454.00K 10-Q · filed 2023-08-09 | ||||
| 2022-03-31 | $454.00K 10-Q · filed 2023-05-09 | ||||
| 2022-01-14 | $500.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |